RWA Wealth Partners’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$236K Sell
2,739
-71
-3% -$6.23K ﹤0.01% 611
2026
Q1
$254K Sell
2,810
-225
-7% -$20.6K ﹤0.01% 573
2025
Q4
$273K Sell
3,035
-1,545
-34% -$146K ﹤0.01% 541
2025
Q3
$451K Buy
4,580
+1,495
+48% +$148K 0.01% 458
2025
Q2
$281K Hold
3,085
﹤0.01% 518
2025
Q1
$349K Hold
3,085
﹤0.01% 458
2024
Q4
$326K Hold
3,085
﹤0.01% 473
2024
Q3
$333K Hold
3,085
﹤0.01% 458
2024
Q2
$335K Sell
3,085
-12
-0.4% -$1.42K ﹤0.01% 440
2024
Q1
$409K Buy
3,097
+12
+0.4% +$1.5K 0.01% 418
2023
Q4
$375K Buy
+3,085
New +$344K 0.01% 411
2018
Q3
Sell
-1,316
Closed -$142K 717
2018
Q2
$142K Sell
1,316
-42
-3% -$4.57K 0.02% 270
2018
Q1
$144K Buy
+1,358
New +$158K 0.02% 227

Other funds holding ZBH

RWA Wealth Partners's ZBH Position: Q2 2026 in Review

RWA Wealth Partners reduced its Zimmer Biomet (ZBH) stake by 2.5% in Q2 2026, selling an estimated $6.23K and leaving 2,739 shares worth $236K. The position accounts for ﹤0.01% of the portfolio, ranked #611.

RWA Wealth Partners first reported a position in ZBH in Q1 2018 and has held it in 13 quarters since. The position peaked at $451K in Q3 2025. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • RWA Wealth Partners held 2,739 shares of Zimmer Biomet worth $236K as of Q2 2026.
  • RWA Wealth Partners sold 71 Zimmer Biomet shares in Q2 2026, an estimated $6.23K.
  • Zimmer Biomet made up ﹤0.01% of RWA Wealth Partners's portfolio in Q2 2026, its #611 holding.
  • RWA Wealth Partners first reported a position in Zimmer Biomet in Q1 2018 and has held it in 13 quarters since.
  • RWA Wealth Partners's Zimmer Biomet position peaked at $451K in Q3 2025.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on RWA Wealth Partners's 13F filing for Q2 2026, filed 7 Aug 2026.